Methods for identifying metabolites, and for developing and evaluating therapeutic agents based on the same
WO2026024676A1PCT designated stage Publication Date: 2026-01-29ENVEDA THERAPEUTICS INC
Patent Information
- Application Number
- PCT/US2025/038586
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-07-22
- Filing Date
- 2025-07-22
- Publication Date
- 2026-01-29
Smart Images

Figure US2025038586_29012026_PF_FP_ABST
Abstract
The present disclosure provides a method of identifying a metabolite related to a phenotype of an animal. The method includes obtaining biological samples from a first animal model having a first phenotype and a second animal model having a second phenotype, performing an analysis on the biological samples to identify metabolites with differential abundance between the models, selecting a metabolite with an increased abundance in the first model compared to the second model, administering the selected metabolite to a validation model having the second phenotype, and determining whether administration of the selected metabolite modulates the phenotype of the validation model to transition from the second phenotype toward the first phenotype. The method enables identification of potential therapeutic metabolites for treating diseases associated with metabolic imbalances.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Substances for treatment of fatty liver-related conditions
US20210401787A1
IROA Metabolomics Workflow for Improved Accuracy, Identification and Quantitation
US20220037139A1
Immunological effects of metabolites
US20230330040A1
Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis
WO2021113989A1